RMD vs COO — Key Metrics

Metric RMD (RESMED INC) COO (COOPER COMPANIES INC)
Price242.6160.75
Market Cap34.12 Billion11.55 Billion
P/E (TTM)22.0420.66
P/B (Quarterly)5.4381.449
P/S (TTM)5.952.73
Net Profit Margin (TTM)27.813.5
Gross Margin (TTM)61.165.9
ROE (TTM)25.16.9
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

RESMED INC
vs
 
COOPER COMPANIES INC
 
RESMED INC
vs
 
COOPER COMPANIES INC
Performance Comparison
AI Model Recommendation
RMD · RESMED INC

Outperform

46
UnderperformOutperform
COO · COOPER COMPANIES INC

Underperform

-29
UnderperformOutperform
Recommendation Summary

Stock RMD is projected to outperform the market, stock COO is projected to underperform the market. Upfront Recommendation: RMD.

Financial Metrics
Prices delayed ~15 min
RMD Metrics COO
$242.61 Price $60.75
— Market Capitalization —
22.04 Price to Earnings Ratio 20.66
5.95 Price to Sales 2.73
21.21 Price to FCF Ratio 17.04
9.75 Price to Gross Profit 4.14
86.65 Price to R&D 68.03
9.73 Price to Current Assets 5.06

RMD vs COO at a glance

Resmed INC (RMD) and Cooper Companies INC (COO) are both Medical Instruments & Supplies companies in the Healthcare sector. RMD is the larger, at $34.1 billion in market value against $11.6 billion for COO, about 3.0 times the size.

On trailing-twelve-month figures, RMD trades at 22.0 times trailing earnings and COO at 20.7; net profit margins are 27.8% and 13.5%.

The Upfront Investment model currently rates RMD Outperform and COO Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.